ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy 
Blockpass and RWA Inc. Partner to Effect Verifiable Trust in Real World Asset & DePIN Tokenization Bamboo Systems Expands Channel Program with New Agreement with Zen Exim
Bamboo embarks on new market opportunities as it engages with India’s leading value added distributor…
Microsoft Research Reveals Changing Habits of the Irish Remote Worker
Global Research reveals that the traditional working models no longer apply and faces potential disruption:…
Fileless Malware Attacks Surge by 900% and Cryptominers Make a Comeback, While Ransomware Attacks Decline
WatchGuard research uncovers massive increases in endpoint attacks, rising rate of encrypted malware and new…
USU Closes Six Figure Contract with Canadian Insurance Leader
Montreal-based firm selects USU as best-of-breed SAM solution BOSTON, MA – March 30, 2021 –…
Tungsten Capital: AI-powered fund as alternative for fixed-income investors
Though treasury yields have been rising recently, they remain low by historical standards. In Europe,…
LIDDS updates on the Clinical Program for Liproca Depot
UPPSALA, SWEDEN – LIDDS AB (publ) announced today an update on the clinical program for…
Tiziana Plans Phase 2 Clinical Study in Moderate to Severe Covid-19 Patients with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
Since the anti-inflammatory effect of the nasally administered Foralumab is through the modulation of the…
Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
Company Announcement Novartis receives European approval for Kesimpta® (ofatumumab) for the treatment of relapsing forms…
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
Companies have successfully submitted the EU regulatory application for marketing authorization for difelikefalin If approved,…
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)
Expands Novartis Oncology radioligand pipeline with exclusive worldwide rights to develop and commercialize therapeutic applications…
Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy
Evrysdi has proven efficacy in adults, children and babies two months and older, as shown…
Publication of Annual Report 2020
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Addition of Voice Lift Technology Further Enhances Performance Capabilities of ClearOne’s BMA 360 Beamforming Microphone Array
Now available worldwide, the Voice Lift upgrade rounds out the BMA 360 offering to include…
Marketers can reach the ‘holy grail’ of proven payers in similar apps with Bango Audiences
CAMBRIDGE, United Kingdom, March 30, 2021 (GLOBE NEWSWIRE) — Bango (AIM: BGO), the global platform…
Natural Language Processing Named a Foundational AI Technology, According to the 2021 AI in Healthcare Survey Report
New Research Explores Tools, Technologies, and Criteria for AI Adoption and Practices Across the Healthcare…
BIO-key Selected as SC Media Trust Award Finalist for Best Authentication Technology
Annual awards honor the best in U.S. cybersecurity, confirming BIO-key as a leader in the…
NSR Report: Space Investments in 2020 Hit $7.7B in Record Year
With VCs Returning to Business as Usual, Investment in Space Reaches $36 Billion Since Turn…
Netsurion Named in the 2021 CRN Partner Program Guide
FORT LAUDERDALE, Fla., March 29, 2021 (GLOBE NEWSWIRE) — Netsurion, a leading managed security service…
Qualia Launches New Marketplace Integrations with DataTrace
SAN FRANCISCO, March 29, 2021 (GLOBE NEWSWIRE) — Qualia, the leading digital real estate closing…
Pax8 Awarded a 5-Star Rating for the 2021 CRN Partner Program Guide
Wingman Partner Program Earns Recognition for Fifth Consecutive Year DENVER, March 29, 2021 (GLOBE NEWSWIRE)…